Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Lowers FY2025 Adj EPS Guidance from $4.45-$4.60 to $4.40-$4.55 vs $4.39 Est; Raises FY2025 Sales Guidance from $1.350B-$1.378B to $1.356B-$1.378B vs $1.362B Est

Author: Benzinga Newsdesk | July 30, 2025 04:05pm
Conmed (NYSE:CNMD) lowers FY2025 Adj EPS guidance from $4.45-$4.60 to $4.40-$4.55 vs $4.39 analyst estimate. Raises FY2025 sales outlook from $1.350 billion-$1.378 billion to $1.356 billion-$1.378 billion vs $1.362 billion estimate.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist